Intellia Therapeutics Inc buy Barclays PLC
Start price
04.08.23
/
50%
€36.00
Target price
04.08.24
€81.52
Performance (%)
-33.22%
Price
17:03
€24.04
Summary
This prediction is currently active. The BUY prediction by Barclays_PLC for Intellia Therapeutics Inc is performing very badly with a performance of -33.22%. This prediction currently runs until 04.08.24. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Intellia Therapeutics Inc | -5.520% | -5.520% |
iShares Core DAX® | -0.612% | 0.567% |
iShares Nasdaq 100 | -3.018% | -3.205% |
iShares Nikkei 225® | -2.647% | 0.330% |
iShares S&P 500 | -1.932% | -1.126% |
Comments by Barclays_PLC for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at Barclays PLC from $148.00 to $90.00. They now have an "overweight" rating on the stock.
Ratings data for NTLA provided by MarketBeat